Luis Sepulveda Garcia
Endocrinology, Diabetes & Metabolism · Humacao, PRNPI 1003342494
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,096 of the $4,706 with a category attached, or 87.0%. It is spread thinly across 25 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,461, more than ten times the $106 reported in 2021. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in PR, where the typical reported total is $4,706.
Across 153 payments — averaging $30.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$648
- Boehringer Ingelheim$503
- Novo Nordisk$440
- AstraZeneca$354
- Sanofi-aventis U.S. LLC$322
- Dexcom, Inc.$248
- plus $2K from 19 others
What the payments were for
- Travel & lodging$54512%
- Food & beverage$4,09687%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $648 |
| Boehringer Ingelheim | 15 | $503 |
| Novo Nordisk | 18 | $440 |
| AstraZeneca | 13 | $354 |
| Sanofi-aventis U.S. LLC | 10 | $322 |
| Dexcom, Inc. | 13 | $248 |
| Eli Lilly Export S.A. Puerto Rico Branch | 10 | $229 |
| Amgen | 5 | $214 |
| Rigel Pharmaceuticals, Inc. | 8 | $190 |
| PBG Puerto Rico LLC | 9 | $172 |
| AbbVie | 7 | $159 |
| Merck | 4 | $154 |
| Novartis | 6 | $136 |
| E.r. Squibb & Sons, L.L.C. | 7 | $126 |
| Corcept Therapeutics | 2 | $125 |
| Madrigal Pharmaceuticals | 1 | $118 |
| Lilly USA, LLC | 1 | $118 |
| BETA Bionics, Inc. | 1 | $116 |
| Bayer Puerto Rico Inc. | 5 | $90 |
| Johnson & Johnson | 3 | $74 |
| Rhythm Pharmaceuticals, Inc. | 2 | $50 |
| Gilead | 2 | $42 |
| Boston Scientific | 1 | $29 |
| Radius Health, Inc. | 1 | $25 |
| Springworks Therapeutics, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$445
- iLet Bionic Pancreas$347
- JARDIANCE$125
- TOUJEO$125
- Repatha$125
- FARXIGA$121
- REZDIFFRA$118
- ZEPBOUND$118
- iLet Insulin Infusion Kit Inset$116
- iLet Insulin Infusion Kit Contact Detach$116
- Ozempic$107
- Korlym$102
How this compares
$4,706 in reported general payments places this provider in the 50th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $15,063 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 12 | $7,578 |
| SynthroidLevothyroxine Sodium | 59 | $3,559 |
| LantusInsulin Glargine,hum.Rec.Anlog | 22 | $1,855 |
| HumalogInsulin Lispro | 12 | $1,160 |
| Hydrocortisone | 16 | $657 |
| Atorvastatin Calcium | 40 | $311 |
| Rosuvastatin Calcium | 13 | $305 |
| Losartan Potassium | 11 | $115 |
| Prednisone | 13 | $114 |
| Metformin Hcl | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Humalog | $118 | $16,22226 claims |
| Boehringer IngelheimTrijardy Xr | $503 | $7,57812 claims |
| AbbVieSynthroid | $159 | $3,55959 claims |
| Sanofi-aventis U.S. LLCLantus | $322 | $1,85522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in Humacao
- Myriam Allende-VigoHumacao$12K
- Jose Garcia MateoPonce$945K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Alex Gonzalez BossoloSan Juan$110K
- Michelle Mangual GarciaSan Juan$87K
- Meliza Martinez RodriguezSan Juan$80K
- Milliette Alvarado SantiagoRio Piedras$75K
- Altagracia Alcantara GonzalezBayamon$58K
- Jean Pujals KuryBayamon$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.